Trial Profile
Efficacy of alogliptin/metformin combination tablets(INISYNC combination tablets) in type 2 diabetic patients
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 26 Oct 2018
Price :
$35
*
At a glance
- Drugs Alogliptin/metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 26 Oct 2018 New trial record